Quinacrine non-surgical female sterilization in Bangladesh.
This study was undertaken to evaluate the efficacy, safety, and acceptability of transcervical applications of quinacrine along with other adjuvants, such as ampicillin and ibuprofen, for sterilization. The cohort consisted of 750 normal women who requested sterilization and volunteered for this method at the family planning clinic of a tertiary hospital and community clinics in Chittagong, Bangladesh. Several different protocols were followed from October 1989 to April 1999. Each woman received one or two insertions of 180 mg or 252 mg quinacrine with or without adjuvants including 55.5 mg ibuprofen or 125 mg ampicillin. Supplementary contraception was given in the form of combined oral contraceptive pills, barrier methods, or injection of depot medroxyprogesterone acetate for 3 months. Details of each protocol are described in the text. The gross pregnancy failure rate for insertion of 180 mg in 590 women was 3.9% compared to 1.9% for the 160 who received 252 mg. There were no serious complications, and side effects were transient. We conclude that quinacrine non-surgical sterilization is a safe, acceptably effective method when two insertions of 252 mg quinacrine with medroxyprogesterone injection as a supplement is used.
Bhuiyan
S N
SN
Department of Obstetrics and Gynecology, Chittagong Medical College, Chittagong, Bangladesh. unigmt@ctg.dolphi.net
Begum
R
R
D000328:Adult; D001459:Bangladesh; D003362:Cost-Benefit Analysis; D004522:Educational Status; D005260:Female; D006801:Humans; D008875:Middle Aged; D011247:Pregnancy; D011796:Quinacrine / Q000627:therapeutic use*; D012424:Rural Population; D013245:Sterilization, Reproductive / Q000009:adverse effects*; D016896:Treatment Outcome
D011796:Quinacrine